Presented by Incubate, America's medicine cabinet is running out. Researchers are advancing

cures for cancer, Alzheimer's, and more, but the pill penalty is putting progress on pause.

It slaps price controls on pills years earlier than other medicines, stalling investment and denying

hope to millions. Through budget reconciliation, Congress can

fix it. It's time to act and end the pill penalty.

Hey everybody. It's Anna Palmer from The Daily Punch. Welcome to our fourth and final special edition podcast for the future of medicine, a custom project. Over the past few weeks, we've been laying out the state of play, the legislative landscape, hearing from key lawmakers and players in the space, and the outlook on what's to come.

A big thank you to incubate for making this podcast and product possible.

You can check out the full project and all of the features at punchable.

Today, I'm going to be joined by our financial services reporter, Brendan Peterson, who took the mantle on our fourth feature, focused on the players in the space.

Brendan, thanks so much for joining us.

Thanks for having me.

Good to be here.

As you well know here at Punchable News, we often say people are policy.

They are what actually matters.

And you write, Brendan, that the future of the life

sciences depends on a complicated relationship among several entities working to influence the

direction of health care policy. These policymakers working on legislation that will shape

the industry for a long time, government agencies writing the rules and overseen the sector,

and of course, industry and advocacy groups pushing for policy that works in their favor.

So 100,000 feet set the stage for us before we get into all the different universes and

kind of who's doing one and pushing what kind of policies. What is at stake and what are

advocates focused on when it comes to the future of medicine?

...